Vancomycin concentrations were not reported uniformly, and the level at the time of neutrophil nadir was not always reported, which would affect the interpretation of the correlation between ...

But a second asteroid struck during that same era at the Nadir crater off the coast of Guinea in western Africa -- proving once and for all that nature really had it in for the poor dinos.

While Syfovre’s revenue miss is no doubt disappointing, the drug remained the market leader in GA with more than 88,500 doses delivered to physicians in the third quarter, Apellis said in its ...

At the European Society for Medical Oncology (ESMO) Congress this week, investigators presented data for a new and potentially important drug, ribociclib (Novartis). This oral medication is ...

Dr Uisdean Nicholson from Heriot-Watt University first found the Nadir crater in 2022, but a cloud of uncertainty hung over how it was really formed. Now Dr Nicholson and his colleagues are sure ...

The side effects were similar in both groups, with the most common issues being neutropenia, arthralgia and liver-related events. "Overall, the NATALEE trial supports support ribociclib plus endocrine ...

Ribociclib in combination with an aromatose inhibitor for previously untreated advanced or metastatic hormone receptor-positive, her2-negative breast cancer. The NICE appraisal committee wanted to ...

The drug, also known as ribociclib, has been approved for use ... with Kisqali medicine are low white blood cell count or ...

Their research suggested that neoadjuvant therapy with a combination of ribociclib and letrozole could be an alternative to multi-drug neoadjuvant chemotherapy. The trial involved high risk ...

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

The US FDA has approved Kisqali (ribociclib) for treating early-stage ... with Kisqali medicine are low white blood cell count or neutropenia. Neutropenia occurs when there are lower levels ...